טוען...
Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study
Hypertriglyceridemia, defined as a triglyceride measurement > 150 mg/dl, occurs in up to 34% of adults. Fenofibrate is a commonly used drug to treat hypertriglyceridemia, but response to fenofibrate varies considerably among individuals. We sought to determine if genetic variation in apolipoprote...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The American Society for Biochemistry and Molecular Biology
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2952572/ https://ncbi.nlm.nih.gov/pubmed/20724655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.P001834 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|